Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zheng-Yin Pan

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Dalton Transactions (Cambridge, England : 2003)|August 9, 2020
Dinuclear phosphorescent rhenium(I) complexes as potential anticancer and photodynamic therapy agentsZheng-Yin Pan, Dai-Hong Cai, Liang He
Chemical Communications (Cambridge, England)|June 28, 2022
Photodegradation of carbonic anhydrase IX <i>via</i> a binding-enhanced ruthenium-based photosensitizerLiang Hao, Jie Wang, Zheng-Yin Pan, et al.
Dalton Transactions (Cambridge, England : 2003)|March 4, 2020
Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapyWei-Wei Qin, Zheng-Yin Pan, Dai-Hong Cai, et al.
Journal of Medicinal Chemistry|November 10, 2022
Pt(IV)-Deferasirox Prodrug Combats DNA Damage Repair by Regulating RNA N<sup>6</sup>-Methyladenosine MethylationZheng-Yin Pan, Yu-Yi Ling, Hang Zhang, et al.
Dalton Transactions (Cambridge, England : 2003)|March 14, 2019
Impairment of the autophagy-related lysosomal degradation pathway by an anticancer rhenium(i) complexLiang He, Zheng-Yin Pan, Wei-Wei Qin, et al.
Dalton Transactions (Cambridge, England : 2003)|May 25, 2023
Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acidsBai-Hua Chen, Zheng-Yin Pan, Wen-Wen Feng, et al.
ACS Applied Materials & Interfaces|September 5, 2020
Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal TherapyGang-Gang Yang, Zheng-Yin Pan, Dong-Yang Zhang, et al.
Chemical Science|November 2, 2022
A platinum-ruthenium hybrid prodrug with multi-enzymatic activities for chemo-catalytic therapy of hypoxic tumorsGang-Gang Yang, Xu-Xian Su, Bing-Bing Liang, et al.
National Science Review|August 12, 2022
Real-time tracking of ER turnover during ERLAD by a rhenium complex via lifetime imagingLiang Hao, Yu-Yi Ling, Zhi-Xin Huang, et al.
Angewandte Chemie (International Ed. in English)|June 20, 2020
CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic TumorsQian Cao, Dan-Jie Zhou, Zheng-Yin Pan, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Dalton Transactions (Cambridge, England : 2003)|August 9, 2020
Dinuclear phosphorescent rhenium(I) complexes as potential anticancer and photodynamic therapy agentsZheng-Yin Pan, Dai-Hong Cai, Liang He
Chemical Communications (Cambridge, England)|June 28, 2022
Photodegradation of carbonic anhydrase IX <i>via</i> a binding-enhanced ruthenium-based photosensitizerLiang Hao, Jie Wang, Zheng-Yin Pan, et al.
Dalton Transactions (Cambridge, England : 2003)|March 4, 2020
Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapyWei-Wei Qin, Zheng-Yin Pan, Dai-Hong Cai, et al.
Journal of Medicinal Chemistry|November 10, 2022
Pt(IV)-Deferasirox Prodrug Combats DNA Damage Repair by Regulating RNA N<sup>6</sup>-Methyladenosine MethylationZheng-Yin Pan, Yu-Yi Ling, Hang Zhang, et al.
Dalton Transactions (Cambridge, England : 2003)|March 14, 2019
Impairment of the autophagy-related lysosomal degradation pathway by an anticancer rhenium(i) complexLiang He, Zheng-Yin Pan, Wei-Wei Qin, et al.
Dalton Transactions (Cambridge, England : 2003)|May 25, 2023
Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acidsBai-Hua Chen, Zheng-Yin Pan, Wen-Wen Feng, et al.
ACS Applied Materials & Interfaces|September 5, 2020
Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal TherapyGang-Gang Yang, Zheng-Yin Pan, Dong-Yang Zhang, et al.
Chemical Science|November 2, 2022
A platinum-ruthenium hybrid prodrug with multi-enzymatic activities for chemo-catalytic therapy of hypoxic tumorsGang-Gang Yang, Xu-Xian Su, Bing-Bing Liang, et al.
National Science Review|August 12, 2022
Real-time tracking of ER turnover during ERLAD by a rhenium complex via lifetime imagingLiang Hao, Yu-Yi Ling, Zhi-Xin Huang, et al.
Angewandte Chemie (International Ed. in English)|June 20, 2020
CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic TumorsQian Cao, Dan-Jie Zhou, Zheng-Yin Pan, et al.
Pageof 2